(Q38463964)

3 September 2017

Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome (English)

1 reference

3 September 2017

Epling-Burnette PK

1

1 reference

3 September 2017

Painter JS

2

1 reference

3 September 2017

Rollison DE

3

1 reference

3 September 2017

Ku E

4

1 reference

3 September 2017

Vendron D

5

1 reference

3 September 2017

Widen R

6

1 reference

3 September 2017

Boulware D

7

1 reference

3 September 2017

Zou JX

8

1 reference

3 September 2017

Bai F

9

1 reference

3 September 2017

List AF

10

1 reference

3 September 2017

15 February 2007

1 reference

3 September 2017

1 reference

3 September 2017

21

1 reference

3 September 2017

659-667

1 reference

3 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404590

3 September 2017

0 references

cites work

Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

T cell receptor repertoire in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

Myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

NKG2D is a costimulatory receptor for human naive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Thalidomide's ability to augment the synthesis of IL-2 in vitro in HIV-infected patients is associated with the percentage of CD4+ cells in their blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Antithymocyte globulin for patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Immune pathophysiology of aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Immune pathophysiology of aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Large Granular Lymphocyte Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Application of the Molecular Analysis of the T-Cell Receptor Repertoire in the Study of Immune-Mediated Hematologic Diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Killer cell immunoglobulin-like receptor expression delineates in situ Sézary syndrome lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

The relationship of aplastic anemia and PNH.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Estimate of the total number of CD8+ clonal expansions in healthy adults using a new DNA heteroduplex-tracking assay for CDR3 repertoire analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

High-resolution analysis of T-cell receptor beta-chain repertoires using DNA heteroduplex tracking: generally stable, clonal CD8+ expansions in all healthy young adults.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Application of the International Prognostic Scoring System for myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

How NKG2D ligands trigger autoimmunity?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

The role of the NKG2D immunoreceptor in immune cell activation and natural killing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Enhanced purification of fetal liver hematopoietic stem cells using SLAM family receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Human CD8+ CTL recognition and in vitro lysis of herpes simplex virus-infected cells by a non-MHC restricted mechanism.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Memory T-cell competition for bone marrow seeding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

HLA‐DR4 predicts haematological response to cyclosporine in T‐large granular lymphocyte lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404590

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404590

1 reference

Dimensions Publication ID

3 September 2017

1018417334

0 references

Fatcat ID

release_rpxonfca7fhundox63z7bnoldu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rpxonfca7fhundox63z7bnoldu

24 November 2022

mapped directly with Wikidata item

1 reference